胰岛素泵医生的系统培训.ppt

Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;胰岛素泵治疗（CSII） ——享受健康生活;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;美敦力公司;MiniMed曾经是一家专门致力于糖尿病领域胰岛素泵及系列产品研究、生产、销售的医疗高科技公司，也是第一个通过FDA认证的胰岛素泵发源地。市场占有率：全世界第一 中国第一;美敦力MiniMed 公司在胰岛素泵治疗和连续血糖监测方面处于世界领先地位。 它从70年代末开始胰岛素泵的研制和生产。很多用户在十多年前买了MiniMed 公司胰岛素泵便连续佩带到今天。 今天，超过15万人使用MiniMed 的胰岛素泵。美敦力MiniMed 公司致力于用先进的技术和良好的服务帮助糖尿病人获得更多健康和正常生活。 ;Roper-Starch Global Diabetes Report;Roper-Starch Global Diabetes Report;6 Major Countries in EU ~ 735,000 4 ;Evolution of Diabetes Management Technologies糖尿病治疗技术的进展;History of Pumps胰岛素泵的历史-七十年代;现在的胰岛素泵系统;正常胰腺胰的胰岛素分泌曲线;Intermediate Regular Insulin中效和常规胰岛素的使用 Lack of consistency between insulin effect causes large variations in BG levels Flexibility is a difficult challenge;Glargine Rapid Acting Insulin长效和速效胰岛素的使用 Would be more physiological if insulin, exercise, meals were predictable 如果胰岛素,运动,用餐量事先预测,可以把血糖控制接近正常 Lifestyle flexibility supposedly improved---但生活自由度受到很大限制;Basal Bolus Faster-acting Insulin---基础率和餐前大剂量 Combined with SMBG, physiological insulin requirements can be more closely achieved结合测血糖,几乎可以达到接近生理需要的胰岛素量 Flexibility in lifestyle---生活自由;Basal Rate---基础率 Preprogrammed Continuous flow of fast-acting insulin Matching variable metabolic needs ;DCCT研究中使用胰岛素泵病人的比率;减少低血糖的发生;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;总体费用的减少;CSII vs. MDI Uses only faster-acting insulin:CSII只用短效胰岛素或速效胰岛素,MDI使用中效或长效胰岛素. More predictable absorption than modified insulins (variation 3% vs. 52%):CSII的吸收差异率小于3%,MDI的吸收差异率可达到10-52%. Uses one infusion site:CSII相对固定的一个注射点 Reduces variations in absorption due to site rotation Eliminates most of the subcutaneous insulin depot:CSII消除皮下蓄积 Programmable delivery simulates normal pancreatic function:CSII模拟正常胰腺的功能;胰岛素泵治疗的好处（一）;胰岛素